| First Author | Jin Z | Year | 2017 |
| Journal | PLoS Genet | Volume | 13 |
| Issue | 3 | Pages | e1006672 |
| PubMed ID | 28296893 | Mgi Jnum | J:241364 |
| Mgi Id | MGI:5901961 | Doi | 10.1371/journal.pgen.1006672 |
| Citation | Jin Z, et al. (2017) hnRNP I regulates neonatal immune adaptation and prevents colitis and colorectal cancer. PLoS Genet 13(3):e1006672 |
| abstractText | The intestinal epithelium plays a critical role in host-microbe homeostasis by sensing gut microbes and subsequently initiating proper immune responses. During the neonatal stage, the intestinal epithelium is under immune repression, allowing the transition for newborns from a relatively sterile intra-uterine environment to one that is rich in foreign antigens. The mechanism underlying such immune repression remains largely unclear, but involves downregulation of IRAK1 (interleukin-1 receptor-associated kinase), an essential component of toll-like receptor-mediated NF-kappaB signaling. We report here that heterogeneous nuclear ribonucleoprotein I (hnRNPI), an RNA binding protein, is essential for regulating neonatal immune adaptation. We generated a mouse model in which hnRNPI is ablated specifically in the intestinal epithelial cells, and characterized intestinal defects in the knockout mice. We found that loss of hnRNPI function in mouse intestinal epithelial cells results in early onset of spontaneous colitis followed by development of invasive colorectal cancer. Strikingly, the epithelium-specific hnRNPI knockout neonates contain aberrantly high IRAK1 protein levels in the colons and fail to develop immune tolerance to environmental microbes. Our results demonstrate that hnRNPI plays a critical role in establishing neonatal immune adaptation and preventing colitis and colorectal cancer. |
